On Oct. 12, 2017, the NIH and 11 leading biopharmaceutical companies launched the Partnership for Accelerating Cancer Therapies (PACT), a five-year public-private research collaboration totaling $215 million as part of the Cancer Moonshot.

PACT initially focused on efforts to identify, develop and validate robust biomarkers to advance new immunotherapy treatments that harness the immune system to attack cancer.